Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

Related PLOS Journal: PLOS Medicine

Showing 41 to 50 of 90 posts
  • A PLOS Collection Reporting Guidelines

    Reporting guidelines are statements intended to advise authors reporting research methods and findings. They can be presented as a checklist, flow diagram or text, and describe what is required to…

    View Collection
  • A PLOS Collection Malaria: Targets and Drugs for All Stages

    Drug research in malaria often focuses on blood stage parasites because they are responsible for the symptoms of the disease and are easier to manipulate in the laboratory.This collection describes…

    View Collection
  • A PLOS Collection The Changing Nature of Global Health Institutions

    In January 2010 PLOS Medicine launched a four-part series examining the ways in which global health institutions and arrangements are changing and evolving. The series aims to stimulate debate…

    View Collection
  • A PLOS Collection Ghostwriting Collection

    Ghostwriting occurs when someone has made substantial contributions to writing a manuscript but this role is unacknowledged. In medicine, ghostwriting is problematical because it often involves…

    View Collection
  • A PLOS Collection Genomics of Emerging Infectious Diseases

    This collection of essays, perspectives, and reviews from six PLOS journals provides insights into how genomics can revolutionize our understanding of emerging infectious disease. Produced with…

    View Collection
  • A PLOS Collection Epigenetics 2010

    Epigenetics is the study of inherited changes in phenotype or gene expression caused by mechanisms other than changes in the underlying DNA sequence. This collection brings together twenty research…

    View Collection
  • A PLOS Collection Are Drug Companies Living Up to Their Human Rights Responsibilities? Three Viewpoints

    In September 2010, the PLOS Medicine Debate asked whether drug companies are living up to their human rights responsibilities. Sofia Gruskin and Zyde Raadfrom the Harvard School of Public Health say…

    View Collection
  • A PLOS Collection Disease Mongering

    To mark the first academic meeting on disease mongering (the "selling of sickness" in order to promote drug sales), which was held in Newcastle, Australia in April 2006, and to help provoke…

    View Collection
  • A PLOS Collection Open Data

    In the spirit of Open Con and highlighting the state of Open Data, PLOS is proud to release our Open Data Collection. In collaboration with our external advisor, Melissa Haendel, we have selected…

    View Collection
  • A PLOS Collection Translating the Cancer Genome – Implications for Diagnosis and Treatment 

    Dramatic reductions in the cost of sequencing, as well advances in sequencing technologies, have enabled key insights into the genomic alterations and somatic mutations that lead to cancer and…

    View Collection
Back to top